Keppra and Mucomyst drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Keppra (levetiracetam) and Mucomyst (acetylcysteine). Common drug interactions include pneumonia among females and hypertension among males.

The phase IV clinical study analyzes what interactions people have when they take Keppra and Mucomyst. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.

What is Mucomyst?

Mucomyst has active ingredients of acetylcysteine. eHealthMe is studying from 1,835 Mucomyst users. Check the latest studies of Mucomyst.

On Jul, 19, 2026

39 people who take Keppra and Mucomyst together, and have interactions are studied.

What are the common drug interactions of Keppra and Mucomyst, by gender? *:

female:

Pneumonia
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Muscular weakness (muscle weakness)
Blood glucose increased
Cardiac arrest
Dehydration (dryness resulting from the removal of water)
Hypovolaemia (a decreased volume of circulating blood in the body)
Lethargy (tiredness)
Neurogenic bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion)
Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)

male:

Hypertension (high blood pressure)
Infection
Fall
Hyperkalaemia (damage to or disease of the kidney)
Hypotension (abnormally low blood pressure)
Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
Pneumonia
Renal failure (kidney dysfunction)
Respiratory failure (inadequate gas exchange by the respiratory system)
Sepsis (a severe blood infection that can lead to organ failure and death)

What are the common drug interactions of Keppra and Mucomyst, by age (0-1 to 60+)? *:

0-1:

Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)

2-9:

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Muscular weakness (muscle weakness)
Pneumonia
Hypertension (high blood pressure)
Infection
Anticonvulsant drug level below therapeutic
Blood glucose increased
Cardiac arrest
Dehydration (dryness resulting from the removal of water)
Hypovolaemia (a decreased volume of circulating blood in the body)

10-19:

Pneumonia
Respiratory tract infection

20-29:

Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)

30-39:

n/a

40-49:

Hiv antibody positive
Meningitis viral (viral inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
Aphasia (damage to the parts of the brain that control language)
Confusional state
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Tremor (trembling or shaking movements in one or more parts of your body)

50-59:

Hypertensive hydrocephalus (abnormal expansion of cavities (ventricles) within the brain that is caused by high blood pressure)
Pruritus (severe itching of the skin)

60+:

Crystal nephropathy (crystal induced injury to kidney)
Atelectasis (partial or complete collapse of the lung)
Renal failure (kidney dysfunction)
Respiratory failure (inadequate gas exchange by the respiratory system)
Sepsis (a severe blood infection that can lead to organ failure and death)
Sputum increased
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Dyspnoea (difficult or laboured respiration)
Electrolyte imbalance
Fall

What are the existing conditions these people have? *

Pain: 8 people, 20.51%
Fever: 8 people, 20.51%
Hypotension (abnormally low blood pressure): 6 people, 15.38%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 6 people, 15.38%
Cerebral Palsy: 5 people, 12.82%
Renal Tubular Acidosis (medical condition that involves an accumulation of acid in the body due to a failure of the kidneys): 5 people, 12.82%
Agitation (state of anxiety or nervous excitement): 5 people, 12.82%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 5 people, 12.82%
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 5 people, 12.82%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 12.82%

* Approximation only. Some reports may have incomplete information.

Do you take Keppra and Mucomyst?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously